SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

MELLONI, Elisabetta
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 7.528
AS - Asia 3.812
EU - Europa 2.332
SA - Sud America 562
AF - Africa 88
OC - Oceania 9
Continente sconosciuto - Info sul continente non disponibili 2
Totale 14.333
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.362
SG - Singapore 1.438
CN - Cina 881
IT - Italia 559
BR - Brasile 453
VN - Vietnam 446
DE - Germania 382
HK - Hong Kong 299
PL - Polonia 273
UA - Ucraina 260
GB - Regno Unito 245
TR - Turchia 194
FI - Finlandia 129
BD - Bangladesh 125
FR - Francia 122
RU - Federazione Russa 101
CA - Canada 93
JP - Giappone 85
IN - India 84
SE - Svezia 77
ID - Indonesia 73
NL - Olanda 47
MX - Messico 42
AR - Argentina 36
ZA - Sudafrica 36
ES - Italia 31
IQ - Iraq 29
PK - Pakistan 24
EC - Ecuador 18
BE - Belgio 17
CO - Colombia 17
SA - Arabia Saudita 17
LT - Lituania 16
AT - Austria 15
PH - Filippine 14
UZ - Uzbekistan 14
MY - Malesia 13
AE - Emirati Arabi Uniti 11
CL - Cile 11
MA - Marocco 11
VE - Venezuela 11
CZ - Repubblica Ceca 9
AU - Australia 8
DZ - Algeria 8
TN - Tunisia 8
DO - Repubblica Dominicana 7
EG - Egitto 7
JO - Giordania 7
BO - Bolivia 6
CR - Costa Rica 6
IL - Israele 6
JM - Giamaica 6
KE - Kenya 6
PY - Paraguay 6
GR - Grecia 5
RO - Romania 5
RS - Serbia 5
TW - Taiwan 5
AL - Albania 4
DK - Danimarca 4
HN - Honduras 4
KG - Kirghizistan 4
PT - Portogallo 4
SK - Slovacchia (Repubblica Slovacca) 4
SY - Repubblica araba siriana 4
AZ - Azerbaigian 3
BG - Bulgaria 3
CI - Costa d'Avorio 3
IR - Iran 3
KR - Corea 3
KZ - Kazakistan 3
LA - Repubblica Popolare Democratica del Laos 3
LB - Libano 3
NP - Nepal 3
OM - Oman 3
PS - Palestinian Territory 3
AO - Angola 2
BH - Bahrain 2
CH - Svizzera 2
ET - Etiopia 2
GE - Georgia 2
GT - Guatemala 2
IE - Irlanda 2
LV - Lettonia 2
MD - Moldavia 2
MN - Mongolia 2
QA - Qatar 2
SR - Suriname 2
TT - Trinidad e Tobago 2
UY - Uruguay 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BA - Bosnia-Erzegovina 1
BS - Bahamas 1
BY - Bielorussia 1
EE - Estonia 1
EU - Europa 1
GI - Gibilterra 1
HR - Croazia 1
HU - Ungheria 1
KH - Cambogia 1
Totale 14.320
Salva come PNG Salva come JPEG
Città #
Ashburn 929
Singapore 901
Fairfield 708
Woodbridge 560
San Jose 508
Houston 486
Santa Clara 304
Beijing 296
Hong Kong 295
Chandler 285
Seattle 278
Warsaw 268
Jacksonville 266
Wilmington 247
Cambridge 237
Dallas 223
Ferrara 205
Ann Arbor 181
Ho Chi Minh City 151
Council Bluffs 141
Los Angeles 138
New York 117
Munich 113
Izmir 110
Hanoi 107
Nanjing 83
Tokyo 79
Princeton 72
Lauterbourg 64
San Diego 64
Boardman 58
Jakarta 57
Orem 54
Helsinki 47
Milan 47
Shanghai 40
São Paulo 39
London 38
Buffalo 34
Falls Church 33
Chicago 32
Bologna 31
Montreal 31
Chennai 28
Mexico City 28
Frankfurt am Main 27
Shenyang 25
Nanchang 23
The Dalles 23
Atlanta 22
Denver 22
Dong Ket 22
Johannesburg 22
Turku 22
Hefei 21
Manchester 21
Poplar 21
Brooklyn 20
Dearborn 20
San Mateo 20
Da Nang 19
Rio de Janeiro 19
Tianjin 19
Toronto 19
Stockholm 18
Amsterdam 17
Columbus 17
Haiphong 17
Jiaxing 17
Guangzhou 16
Mumbai 16
Boston 15
Changsha 15
Rome 15
Auburn Hills 14
Brussels 14
Hebei 14
Tashkent 14
Nuremberg 13
Ankara 12
Bremen 12
Falkenstein 12
Montréal 12
San Francisco 12
Baghdad 11
Bari 11
Dhaka 11
Mountain View 11
Ninh Bình 11
Norwalk 11
Phoenix 11
Curitiba 10
Elk Grove Village 10
Jinan 10
Kunming 10
Moscow 10
Tappahannock 10
Zhengzhou 10
Des Moines 9
New Delhi 9
Totale 9.877
Salva come PNG Salva come JPEG
Nome #
Design, synthesis and biological characterization of novel mitochondria targeted dichloroacetate-loaded compounds with antileukemic activity 334
Targeting mTOR in Acute Lymphoblastic Leukemia 293
The anti-leukemic activity of sodium dichloroacetate in p53(mutated/null) cells is mediated by a p53-independent ILF3/p21 pathway 275
Sodium dichloroacetate exhibits anti-leukemic activity in B-chronic lymphocytic leukemia (B-CLL) and synergizes with the p53 activator Nutlin-3 272
Ibrutinib synergizes with MDM-2 inhibitors in promoting cytotoxicity in B chronic lymphocytic leukemia 265
Nutlin-3 up-regulates the expression of Notch1 in both myeloid and lymphoid leukemic cells, as part of a negative feedback antiapoptotic mechanism 261
Crosstalk between adipokines and paraoxonase 1: A new potential axis linking oxidative stress and inflammation 260
Synergistic cytotoxic activity of recombinant TRAIL plus the non-genotoxic activator of the p53 pathway nutlin-3 in acute myeloid leukemia cells 250
Conjunctival sac fluid contains elevated levels of soluble TRAIL: implications for the anti-tumoral surveillance of the anterior surface of the eye 250
Metformin combined with sodium dichloroacetate promotes B leukemic cell death by suppressing anti-apoptotic protein Mcl-1 229
Differential gene expression induction by TRAIL in B chronic lymphocytic leukemia (B-CLL) cells showing high versus low levels of Zap-70 228
TRAIL and Ceruloplasmin Inverse Correlation as a Representative Crosstalk between Inflammation and Oxidative Stress 228
Characterization Methods for Nanoparticle–Skin Interactions: An Overview 226
The MDM-2 antagonist nutlin-3 promotes the maturation of acute myeloid leukemic blasts 225
Human bone marrow mesenchymal stem cells display anti-cancer activity in SCID mice bearing disseminated non-hodgkin's lymphoma xenografts 225
Evidence for a role of TNF-related apoptosis-inducing ligand (TRAIL) in the anemia of myelodysplastic syndromes 224
The p53 transcriptional pathway is preserved in ATMmutated and NOTCH1mutated chronic lymphocytic leukemias 224
Kinetic Profiles of Inflammatory Mediators in the Conjunctival Sac Fluid of Patients upon Photorefractive Keratectomy 215
Cyclooxygenase-2 expression is induced during human megakaryopoiesis and characterizes newly formed platelets 214
Extracellular Tat activates c-fos promoter in low serum-starved CD4+ T cells 212
Eosinophils and purinergic signaling in health and disease 205
The Sorafenib plus Nutlin-3 combination promotes synergistic cytotoxicity in acute myeloid leukemic cells irrespectively of the FLT3 and p53 status 204
Combined treatment of CpG-oligodeoxynucleotide with Nutlin-3 induces strong immune stimulation coupled to cytotoxicity in B-chronic lymphocytic leukemic (B-CLL) cells 202
The MDM2 inhibitor Nutlin-3 attenuates streptozotocin-induced diabetes mellitus and increases serum level of IL-12p40. 201
Relationship between low levels of circulating TRAIL and atheromatosis progression in patients with chronic kidney disease 198
Release of a specific set of proinflammatory adipokines by differentiating 3T3-L1 cells 191
Tumor necrosis factor-related apoptosis-inducing ligand promotes migration of human bone marrow multipotent stromal cells 188
Potential role of PKC inhibitors in the treatment of hematological malignancies 182
Autoinflammatory diseases and cytokine storms-imbalances of innate and adaptative immunity 179
Role of the RANKL/RANK system in the induction of interleukin-8 (IL-8) in B chronic lymphocytic leukemia (B-CLL) cells 176
Genistein exerts in vitro anti-inflammatory effects via NLRP3 modulation in a keratinocyte model 174
The gamma-secretase inhibitors enhance the anti-leukemic activity of ibrutinib in B-CLL cells 173
Microfluidic Fabricated Liposomes for Nutlin-3a Ocular Delivery as Potential Candidate for Proliferative Vitreoretinal Diseases Treatment 171
Role of full-length osteoprotegerin in tumor cell biology. 171
Role of CREB transcription factor in c-fos activation in natural killer cells. 170
Human skin volatilome: a pleiotropic tool to study inflammatory skin conditions 168
Sorafenib inhibits in vitro osteoclastogenesis by down-modulating Mcl-1 168
In vitro apoptotic cell death during erythroid differentiation 166
C reactive protein down-regulates TNF-related apoptosis inducing ligand expression in human peripheral monocytes via an Egr-1 dependent pathway. 163
Colorectal cancer study with nanostructured sensors: Tumor marker screening of patient biopsies 163
Merkel-cell polyomavirus (MCPyV) is rarely associated to B-chronic lymphocytic leukemia (1 out of 50) samples and occurs late in the natural history of the disease 161
Baseline and overtime variations of soluble adhesion molecule plasma concentrations are associated with mobility recovery after rehabilitation in multiple sclerosis patients 160
Evaluation of Anticancer Activity of Nucleoside-Nitric Oxide Photo-Donor Hybrids 157
Role of vitamin D in the pathogenesis of atheromatosis 157
TRAIL, OPG, and TWEAK in kidney disease: biomarkers or therapeutic targets? 155
The oncogene DEK promotes leukemic cell survival and is downregulated by both nutlin-3 and chlorambucil in B-chronic lymphocytic leukemic cells 151
Tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) and TNF-α promote the NF-κB-dependent maturation of normal and leukemic myeloid cells 149
Supravital exposure to propidium iodide identifies apoptosis on adherent cells 148
Human collecting lymphatic glycocalyx identification by electron microscopy and immunohistochemistry 145
SOCS1 is significantly up-regulated in Nutlin-3-treated p53 wild-type B chronic lymphocytic leukemia (BCLL) samples and shows an inverse correlation with miR-155 145
TRICALCIUM PHOSPHATE STIMULATES ADIPOSE TISSUE-DERIVED STEM CELLS TOWARDS OSTEOBLASTS DIFFERENTIATION 144
MCL1 down-regulation plays a critical role in mediating the higher anti-leukaemic activity of the multi-kinase inhibitor Sorafenib with respect to Dasatinib 142
Convolvulus pluricaulis Choisy’s Extraction, Chemical Characterization and Evaluation of the Potential Effects on Glycaemic Balance in a 3T3-L1 Adipocyte Cell Model 139
Acute Neurological Involvement after Donor Lymphocyte Infusion for Post-Transplant Viral Infection: The Same Pattern of Novel Cancer Immunotherapy-Related CNS Toxicity? 139
Selection and characterization of a novel agonistic human recombinant anti-Trail-R2 minibody with anti-leukemic activity 138
The negative prognostic value of TRAIL overexpression in oral squamous cell carcinomas does not preclude the potential therapeutic use of recombinant TRAIL. 135
TRAIL regulates normal erythroid maturation through an ERK-dependent pathway 135
Fine tuning of protein kinase C (PKC) isoforms in cancer: shortening the distance from the laboratory to the bedside. 135
Synthesis and Biological Investigation of Bile Acid-Paclitaxel Hybrids 132
Decreased levels of soluble TNF-related apoptosis-inducing ligand (TRAIL) in the conjunctival sac fluid of patients with diabetes affected by proliferative retinopathy. 125
Overcoming of Microenvironment Protection on Primary Chronic Lymphocytic Leukemia Cells after Treatment with BTK and MDM2 Pharmacological Inhibitors 121
Role of miRNA in adult ocular tumorigenesis 118
Prenylation Defects and Oxidative Stress Trigger the Main Consequences of Neuroinflammation Linked to Mevalonate Pathway Deregulation 118
The response of human natural killer cells to interleukin-2. 115
Dasatinib plus Nutlin-3 shows synergistic anti-leukemic activity in both p53wild-type and p53mutated B chronic lymphocytic leukemias by inhibiting the Akt pathway. 115
The expression levels of the pro-apoptotic XAF-1 gene modulate the cytotoxic response to Nutlin-3 in B chronic lymphocytic leukemia 113
TNFSF10 (tumor necrosis factor Ligand) surfamily,member 10) 112
miR-34a induces the downregulation of both E2F1 and B-Myb oncogenes in leukemic cells. 110
Palmitic Acid Induced a Long-Lasting Lipotoxic Insult in Human Retinal Pigment Epithelial Cells, which Is Partially Counteracted by TRAIL 107
Functional expression of TRAIL and TRAIL-R2 during human megakaryocytic development 103
Mevalonate Kinase Deficiency and Squalene Synthase Inhibitor (TAK-475): The Balance to Extinguish the Inflammation 102
TNF-related apoptosis-inducing ligand (TRAIL) up-regulates cyclooxygenase (COX)-1 activity and PGE(2) production in cells of the myeloid lineage 101
MitoQ is able to modulate apoptosis and inflammation 100
null 96
New Applications of JAK/STAT Inhibitors in Pediatrics: Current Use of Ruxolitinib 95
null 92
null 90
null 89
null 88
null 84
null 83
Perifosine plus nutlin-3 combination shows a synergistic anti-leukaemic activity. 83
Tumor necrosis factor-related apoptosis-inducing ligand induces monocytic maturation of leukemic and normal myeloid precursors through a caspase-dependent pathway 80
Trained Immunity and Its Potential Implications in the Etiopathogenesis of Hidradenitis Suppurativa: A New Paradigm in Chronic Inflammation? 79
null 76
null 76
null 69
PEPTIDE-15 STIMULATES PULP STEM CELLS TOWARDS OSTEOBLASTS DIFFERENTIATION 67
TNF-related apoptosis-inducing ligand (TRAIL) blocks osteoclastic differentiation induced by RANKL plus M-CSF 61
Phytocompounds in Precision Dermatology: COX-2 Inhibitors as a Therapeutic Target in Atopic-Prone Skin 55
Biological Evaluation and SAR Exploration of Bile Acid-Dihydroartemisinin Hybrids as Potential Anticancer Agents for Colorectal Cancer 53
Inverse correlation between circulating levels of TNF-related apoptosis-inducing ligand and 17β-estradiol 52
null 45
Targeting Intestinal Permeability for Graft-versus-Host Disease Treatment: A Therapeutic Perspective with Defibrotide 33
Towards defining the chemical signature of inflammatory skin conditions: an in vitro model 33
TOWARDS DEFINING THE CHEMICAL SIGNATURE OF INFLAMMATORY SKIN CONDITIONS USING VOLATILE METABOLITES: AN IN VITRO MODEL 30
Biological evaluation of dihydroartemisinin-hybrids as potential anticancer agents for colon carcinoma 21
Liposome-loaded Nutlin-3a as a potential candidate for the treatment of proliferative vitreoretinal diseases 18
null 15
Exploratory Volatilome Profiling of Inflammation in Skin Fibroblasts: A Proof-of-Concept Study 10
Totale 14.523
Salva come PNG Salva come JPEG
Categoria #
all - tutte 63.183
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 63.183
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202178 0 0 0 0 0 0 0 0 0 0 0 78
2021/2022764 24 66 50 16 64 51 67 39 28 74 82 203
2022/2023716 83 38 31 78 102 109 39 56 90 7 47 36
2023/2024391 55 32 10 8 28 59 15 40 2 10 16 116
2024/20251.813 46 36 148 87 249 134 71 106 327 170 247 192
2025/20266.109 570 325 488 705 815 374 707 362 645 719 241 158
Totale 14.523